| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,108,000 | 2,293,000 | 2,692,000 | 2,503,000 | | Cost of Revenue | 1,512,000 | (742,000) | 3,262,000 | 1,534,000 | | | Gross Profit | 596,000 | 3,035,000 | (570,000) | 969,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 82,000 | 2,618,000 | (1,176,000) | 625,000 | | Non Recurring |
-
|
-
|
-
| (114,000) | | Others | 183,000 | 179,000 | 162,000 | 171,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 331,000 | 238,000 | 444,000 | 287,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,000 | (239,000) | 155,000 | 36,000 | | Earnings Before Interest And Taxes | 500,000 | 416,000 | 451,000 | 466,000 | | Interest Expense | 82,000 | 88,000 | 67,000 | 38,000 | | Income Before Tax | 418,000 | 328,000 | 384,000 | 428,000 | | Income Tax Expense | 109,000 | 15,000 | 94,000 | 202,000 | | Minority Interest |
-
| (3,000) | (2,000) | (3,000) | | | | Net Income From Continuing Ops | 325,000 | 319,000 | 308,000 | 244,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 325,000 | 319,000 | 308,000 | 244,000 | | Preferred Stock And Other Adjustments | (9,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $316,000 | $319,000 | $308,000 | $244,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
